Roberto Álvarez‐Lafuente

2.6k total citations
76 papers, 1.3k citations indexed

About

Roberto Álvarez‐Lafuente is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Roberto Álvarez‐Lafuente has authored 76 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pathology and Forensic Medicine, 24 papers in Oncology and 24 papers in Immunology. Recurrent topics in Roberto Álvarez‐Lafuente's work include Multiple Sclerosis Research Studies (42 papers), Cytomegalovirus and herpesvirus research (20 papers) and Polyomavirus and related diseases (16 papers). Roberto Álvarez‐Lafuente is often cited by papers focused on Multiple Sclerosis Research Studies (42 papers), Cytomegalovirus and herpesvirus research (20 papers) and Polyomavirus and related diseases (16 papers). Roberto Álvarez‐Lafuente collaborates with scholars based in Spain, United States and Japan. Roberto Álvarez‐Lafuente's co-authors include Rafael Arroyo, Marta García‐Montojo, Virginia de las Heras, Manuel Bartolomé, María Inmaculada Domínguez‐Mozo, Juan J. Picazo, Luisa María Villar, Elena Urcelay, Ignacio Casanova and Rosa Arroyo-García and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Roberto Álvarez‐Lafuente

74 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Álvarez‐Lafuente Spain 22 492 465 344 315 301 76 1.3k
Rafael Arroyo Spain 26 762 1.5× 327 0.7× 333 1.0× 356 1.1× 611 2.0× 76 1.7k
Marta García‐Montojo Spain 20 240 0.5× 276 0.6× 214 0.6× 371 1.2× 183 0.6× 41 1.0k
Giuseppe Mameli Italy 26 345 0.7× 472 1.0× 211 0.6× 748 2.4× 525 1.7× 52 1.8k
Ilijas Jelčić Switzerland 20 473 1.0× 157 0.3× 419 1.2× 153 0.5× 456 1.5× 55 1.5k
Davide Cossu Italy 21 196 0.4× 580 1.2× 113 0.3× 267 0.8× 362 1.2× 66 1.1k
Evelyne Cash France 16 168 0.3× 202 0.4× 175 0.5× 233 0.7× 587 2.0× 30 1.2k
Fiona C. McKay Australia 19 210 0.4× 134 0.3× 132 0.4× 212 0.7× 314 1.0× 33 1.1k
Matthew F. Cusick United States 15 146 0.3× 198 0.4× 82 0.2× 270 0.9× 408 1.4× 48 1.3k
César Sanz-Rodrı́guez Spain 19 186 0.4× 258 0.6× 215 0.6× 417 1.3× 101 0.3× 30 1.2k
Sergio Martínez‐Yélamos Spain 23 671 1.4× 167 0.4× 148 0.4× 165 0.5× 144 0.5× 86 1.5k

Countries citing papers authored by Roberto Álvarez‐Lafuente

Since Specialization
Citations

This map shows the geographic impact of Roberto Álvarez‐Lafuente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Álvarez‐Lafuente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Álvarez‐Lafuente more than expected).

Fields of papers citing papers by Roberto Álvarez‐Lafuente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Álvarez‐Lafuente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Álvarez‐Lafuente. The network helps show where Roberto Álvarez‐Lafuente may publish in the future.

Co-authorship network of co-authors of Roberto Álvarez‐Lafuente

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Álvarez‐Lafuente. A scholar is included among the top collaborators of Roberto Álvarez‐Lafuente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Álvarez‐Lafuente. Roberto Álvarez‐Lafuente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Domínguez‐Mozo, María Inmaculada, et al.. (2025). Immune response profiling of HERV-W envelope proteins in multiple sclerosis: potential biomarkers for disease progression. Frontiers in Immunology. 15. 1505239–1505239. 4 indexed citations
2.
Domínguez‐Mozo, María Inmaculada, Luisa María Villar, Lucienne Costa‐Frossard, et al.. (2025). Short‐chain fatty acids in multiple sclerosis: Associated with disability, number of T2 lesions, and inflammatory profile. Annals of Clinical and Translational Neurology. 12(3). 478–490.
3.
Domínguez‐Mozo, María Inmaculada, Ignacio Casanova, Enric Monreal, et al.. (2024). Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis. International Journal of Molecular Sciences. 25(18). 10012–10012.
4.
Domínguez‐Mozo, María Inmaculada, et al.. (2022). Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study. Frontiers in Immunology. 13. 991662–991662. 10 indexed citations
5.
Domínguez‐Mozo, María Inmaculada, Luisa María Villar, Noelia Villarrubia, et al.. (2022). Mitochondrial Impairments in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients. Biology. 11(11). 1633–1633. 7 indexed citations
6.
Sádaba, María C., Veit Rothhammer, Úrsula Muñoz, et al.. (2020). Serum antibodies to phosphatidylcholine in MS. Neurology Neuroimmunology & Neuroinflammation. 7(4). 17 indexed citations
7.
Moreira, Antía, Elisenda Alari‐Pahissa, Elvira Munteis, et al.. (2019). Adaptive Features of Natural Killer Cells in Multiple Sclerosis. Frontiers in Immunology. 10. 2403–2403. 16 indexed citations
8.
Maza, Susana Sainz de la, Noelia Villarrubia, Roberto Álvarez‐Lafuente, et al.. (2019). Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients. Annals of Clinical and Translational Neurology. 6(2). 355–363. 18 indexed citations
9.
Casrouge, Armanda, Jérémie Decalf, Clara de Andrés, et al.. (2017). Multimarker risk stratification approach at multiple sclerosis onset. Clinical Immunology. 181. 43–50. 9 indexed citations
10.
Varadé, Jezabel, Marta García‐Montojo, Iris Camacho, et al.. (2015). Multiple sclerosis retrovirus-like envelope gene: Role of the chromosome 20 insertion. PubMed. 3. 162–167. 4 indexed citations
11.
Varadé, Jezabel, Marta García‐Montojo, Antonio Alcina, et al.. (2014). Human Endogenous Retrovirus HERV-Fc1 Association with Multiple Sclerosis Susceptibility: A Meta-Analysis. PLoS ONE. 9(3). e90182–e90182. 28 indexed citations
12.
Varadé, Jezabel, Marta García‐Montojo, José Ramón Lamas, et al.. (2013). Role of the Human Endogenous Retrovirus HERV-K18 in Autoimmune Disease Susceptibility: Study in the Spanish Population and Meta-Analysis. PLoS ONE. 8(4). e62090–e62090. 27 indexed citations
13.
García‐Montojo, Marta, María Inmaculada Domínguez‐Mozo, Virginia de las Heras, et al.. (2013). The DNA Copy Number of Human Endogenous Retrovirus-W (MSRV-Type) Is Increased in Multiple Sclerosis Patients and Is Influenced by Gender and Disease Severity. PLoS ONE. 8(1). e53623–e53623. 64 indexed citations
14.
Altınkaya, Sündüz Özlem, et al.. (2011). Coexistence of borderline ovarian epithelial tumor, primary pelvic hydatid cyst, and lymphoepithelioma-like gastric carcinoma. Taiwanese Journal of Obstetrics and Gynecology. 50(2). 201–204. 11 indexed citations
15.
Rollín, Raquel, Roberto Álvarez‐Lafuente, Fernando Marco, et al.. (2009). The ubiquitin–proteasome pathway and viral infections in articular cartilage of patients with osteoarthritis. Rheumatology International. 29(8). 969–972. 8 indexed citations
16.
Álvarez‐Lafuente, Roberto, Marta García‐Montojo, V. De Las Heras, M. Bartolomé, & Rosa Arroyo-García. (2007). Interferon‐beta treatment and active replication of the JC virus in relapsing‐remitting multiple sclerosis patients. European Journal of Neurology. 14(2). 233–236. 12 indexed citations
17.
García‐Montojo, Marta, Virginia de las Heras, Manuel Bartolomé, Rafael Arroyo, & Roberto Álvarez‐Lafuente. (2007). Interferon beta treatment: Bioavailability and antiviral activity in multiple sclerosis patients. Journal of NeuroVirology. 13(6). 504–512. 8 indexed citations
18.
Álvarez‐Lafuente, Roberto, et al.. (2006). Human Herpesvirus 6 and Multiple Sclerosis: A One-Year Follow-up Study. Brain Pathology. 16(1). 20–27. 57 indexed citations
19.
Álvarez‐Lafuente, Roberto, Virginia de las Heras, Manuel Bartolomé, Juan J. Picazo, & Rafael Arroyo. (2004). Beta-Interferon Treatment Reduces Human Herpesvirus-6 Viral Load in Multiple Sclerosis Relapses but Not in Remission. European Neurology. 52(2). 87–91. 17 indexed citations
20.
Álvarez‐Lafuente, Roberto, Virginia de las Heras, Manuel Bartolomé, Juan J. Picazo, & Rafael Arroyo. (2004). Relapsing-Remitting Multiple Sclerosis and Human Herpesvirus 6 Active Infection. Archives of Neurology. 61(10). 1523–1523. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rafael Arroyo Breakdown of academic impact, for papers by Marta García‐Montojo Breakdown of academic impact, for papers by Giuseppe Mameli Breakdown of academic impact, for papers by Ilijas Jelčić Breakdown of academic impact, for papers by Davide Cossu Breakdown of academic impact, for papers by Evelyne Cash Breakdown of academic impact, for papers by Fiona C. McKay Breakdown of academic impact, for papers by Matthew F. Cusick Breakdown of academic impact, for papers by César Sanz-Rodrı́guez Breakdown of academic impact, for papers by Sergio Martínez‐Yélamos
Rankless by CCL
2026